Tabula Rasa HealthCare, Inc. (TRHC) News
Filter TRHC News Items
TRHC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
TRHC News Highlights
- TRHC's 30 day story count now stands at 15.
- Over the past 24 days, the trend for TRHC's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- SAFE, AXON and DECK are the most mentioned tickers in articles about TRHC.
Latest TRHC News From Around the Web
Below are the latest news stories about Tabula Rasa HealthCare Inc that investors may wish to consider to help them evaluate TRHC as an investment opportunity.
Tabula Rasa HealthCare, Inc. 2022 Q4 - Results - Earnings Call PresentationThe following slide deck was published by Tabula Rasa HealthCare, Inc. in conjunction with their 2022 Q4 earnings call.... |
Tabula Rasa HealthCare, Inc. (TRHC) CEO Calvin Knowlton on Q4 2021 Results - Earnings Call TranscriptTabula Rasa HealthCare, Inc. (TRHC) Q4 2021 Earnings Conference Call February 25, 2022, 08:30 AM ET Company Participants Kevin Dill - Corporate Counsel Calvin Knowlton - Founder, Chairman and CEO Orsula Knowlton - Co-Founder, President and Chief Marketing/New Business Development Officer Brian Adams - Co-President Conference Call Participants Sean Dodge... |
Tabula Rasa Healthcare (TRHC) Reports Q4 Loss, Tops Revenue EstimatesTabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -28.57% and 0.76%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |
Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2021 ResultsTabula Rasa HealthCare, Inc. ("TRHC") (Nasdaq: TRHC), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the fourth quarter and full year ended December 31, 2021. |
ZimVie to Join S&P SmallCap 600ZimVie Inc. (NASD:ZIMV) will replace Tabula Rasa Healthcare Inc. (NASD:TRHC) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, March 2. S&P 500 constituent Zimmer Biomet Holdings Inc. (NYSE: ZBH) is spinning off ZimVie in a transaction expected to be completed on March 1. Post spin off, Zimmer Biomet Holdings will remain in the S&P 500. Tabula Rasa Healthcare is no longer representative of the small-cap market space. |
HopeWest to Employ Full Line of TRHC's CareVention HealthCare Offerings to Support PACE StartupTabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, has signed an agreement with HopeWest to implement the full line of TRHC's CareVention HealthCare™ PACE (Program of All-Inclusive Care for the Elderly) services, including risk adjustment, personalized medication safety and pharmacy services, PACE consulting, electronic health record technology implementation, and third party administration. |
Tabula Rasa HealthCare Schedules Fourth Quarter 2021 Earnings Conference CallMOORESTOWN, N.J. , Feb. 10, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC ), will hold a conference call and webcast to discuss its fourth quarter and full year 2021 operating results Friday, February 25, 2022 at 8:30 a.m. EDT . The conference call will be hosted by TRHC CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; TRHC Co-Founder and President, Orsula V. Knowlton , PharmD, MBA; and TRHC Co-President and Chief Financial Officer, Brian W. Adams. The Company''s financial results for the fourth quarter and full year 2021 ending December 31, 2021 , will be released after the close of the market Thursday, February 24, 2021 . … Full story available on Benzinga.com |
Tabula Rasa HealthCare to sell DoseMeRx solutionTabula Rasa HealthCare (TRHC) signed a non-binding letter of intent to sell its DoseMeRx solution |
Tabula Rasa Healthcare to Sell DoseMeRxTabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, announced today that it has signed a non-binding Letter of Intent to sell its DoseMeRx solution. |
A Look At The Fair Value Of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Tabula Rasa... |